Your browser doesn't support javascript.
loading
Crescent calculator: A webtool enabling objective decision-making for assessment of IgA nephropathy immune activity throughout the disease course.
Zhang, Qian; Pan, Hong; Bian, Xue-Yan; Yu, Jin-Han; Wu, Long-Long; Chen, Yi-Dan; Li, Li; Ji, Ling-Xi; Yu, Ya-Li; Han, Fei; Huang, Jian; Wang, Yong-Fei; Yang, Yi.
Afiliação
  • Zhang Q; Department of Nephrology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang University Belt and Road International School of Medicine, Yiwu, China.
  • Pan H; Department of Nephrology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang University Belt and Road International School of Medicine, Yiwu, China.
  • Bian XY; Department of Nephrology, Ningbo First Hospital, Ningbo, China.
  • Yu JH; Warshel Institute for Computational Biology and School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.
  • Wu LL; Department of Nephrology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang University Belt and Road International School of Medicine, Yiwu, China.
  • Chen YD; Warshel Institute for Computational Biology and School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.
  • Li L; Department of Nephrology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang University Belt and Road International School of Medicine, Yiwu, China.
  • Ji LX; Warshel Institute for Computational Biology and School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.
  • Yu YL; Department of Nephrology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang University Belt and Road International School of Medicine, Yiwu, China.
  • Han F; Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
  • Huang J; Department of Nephrology, Jinhua Municipal Central Hospital, Jinhua, China. Electronic address: zjjhzxyyhj@163.com.
  • Wang YF; Warshel Institute for Computational Biology and School of Medicine, The Chinese University of Hong Kong, Shenzhen, China; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: yfwang@cuhk.edu.cn.
  • Yang Y; Department of Nephrology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institutes of Medicine, Zhejiang University, Zhejiang University Belt and Road International School of Medicine, Yiwu, China. Electronic address: yangyixk@zju.edu.cn.
Clin Chim Acta ; 555: 117783, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-38272251
ABSTRACT
IgA nephropathy (IgAN) is an immune-mediated glomerulonephritis, posing a challenge for the long-term management. It is crucial to monitor the disease's activity over the disease course. Crescent lesions have been known as an active lesion associated with immune activity. We aimed to develop the Crescent Calculator to aid clinicians in making timely and well-informed decisions throughout the long-term disease course, such as renal biopsies and immunosuppressive therapy. 1,761 patients with biopsy-proven IgAN were recruited from four medical centers in Zhejiang Province, China. 16.9% presented crescent lesions. UPCR, URBC, eGFR and C4 were independently associated with the crescent lesions. By incorporating these variables, the Crescent Calculator was constructed to estimate the likelihood of crescent lesions. The predictor achieved AUC values of over 0.82 in two independent testing datasets. In addition, to fulfill varied clinical needs, multiple classification modes were established. The Crescent Calculator was developed to estimate the risk of crescent lesions for patients with IgAN, assisting clinicians in making timely, objective, and well-informed decisions regarding the need for renal biopsies and more appropriate use of immunosuppressive therapy in patients with IgAN.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glomerulonefrite / Glomerulonefrite por IGA Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glomerulonefrite / Glomerulonefrite por IGA Idioma: En Ano de publicação: 2024 Tipo de documento: Article